Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
- Resource Type
- Article
- Authors
- Chouinard, Guy; FitzGerald, J Mark; Rostami, Maryam; Oosthuizen, Jean; Pek, Bonavuth; Patel, Deepen; Houle, Pierre-Alain; Laviolette, Michel; Khattak, Sohail; Killorn, Patrick; Keller, Claus; Schenkenberger, Isabelle; Zielen, Stefan; Ballenberger, Sabine; Hoffmann, Martin; Kirschner, Joachim; Papp, Márta; Kecskés, Teréz; Póczi, Magdolna; Molnár, Lajos; Radeczky, Éva; Schlezák, Judit; Springer, Ewa; Balicka, Violetta; Kaczmarek, Jadwiga; Madra-Rogacka, Danuta; Pisarczyk-Bogacka, Ewa; Zurowska-Gebala, Malgorzata; Marczak, Maciej; Napora, Piotr; Pomiecko, Witold; Pribulova, Erika; Kurthova, Svetlana; Drugdova, Maria; Kavkova, Denisa; Frajtova, Luboslava; Golubov, Alexander; Paulinyova, Dagmar; Hasicova, Daniela; Michalickova, Miriam; Trevino, Miguel; Campbell, Charles; Wachtel, Andrew; Bleecker, Eugene; LaForce, Craig; Bernstein, David; Spangenthal, Selwyn; Kerwin, Edward; Mansfield, Lyndon; Ratner, Paul; Arora, Samir; Feldman, Gregory; Okwara, Benedict; Cruz, Humberto; Sher, Lawrence; Pedinoff, Andrew; Corder, Clinton; Ferguson, Gary T; Bleecker, Eugene R; Barker, Peter; Wu, Yanping; Jison, Maria; Goldman, Mitchell
- Source
- In The Lancet Respiratory Medicine July 2017 5(7):568-576
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2213-2600